Taking a prescription medication? See what real patients say about timing, side effects & cash prices. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data

Medications Starting With "G" (47)

Interactive 24-Hour Pill, Supplement & Coffee Clock • FDA DailyMed Spacing + CMS NADAC Cash Price Check

“Can I Take These Together?” Build Your Conflict-Free Daily Schedule

Toggle your prescriptions and supplements below to see stomach mineral absorption blocks, CYP450 conflicts, and your exact 24-hour clock:

1. Select Your Daily Prescriptions & Supplements (Click to Toggle):
⚠ Active Chelation & Co-Factor Audit (FDA DailyMed + NIH RxNorm)
6 Active Items Scheduled Across 4 Conflict-Free Windows
  • 4-Hour Chelation Block (Levothyroxine + Magnesium / Iron): Magnesium and Iron bind to Levothyroxine in the stomach, cutting thyroid absorption by 30%–45%. We automatically moved Iron to 10:30 AM and Magnesium to 9:30 PM.
  • 60-Minute Coffee & Espresso Rule: Brewed coffee sequesters oral T4 tablets inside the intestinal lumen. Wait 45–60 minutes after 6:30 AM Levothyroxine before drinking coffee (or ask about Tirosint gelcaps).
  • Metformin ER + Vitamin B12 Depletion: Long-term Metformin impairs calcium-dependent ileal B12 uptake. Take Metformin ER mid-dinner (6:30 PM) and verify Serum B12 + MMA annually.
  • Atorvastatin / Rosuvastatin + CoQ10 Synergy: Statins inhibit mevalonate synthesis, lowering endogenous CoQ10. Pairing 100–200 mg Ubiquinol with lunch/dinner supports muscle ATP.
6:30 AM • Fasting Water Only
Levothyroxine (Synthroid / Euthyrox)

Take 30–60 min before coffee/breakfast; keep 4 hours away from Iron, Calcium & Magnesium.

Iron Bisglycinate (25–28 mg Elemental)

Alternate-day morning dosing with 200 mg Vitamin C avoids the 24h hepcidin block and protects Levothyroxine.

12:30 PM • Lunch With 15g Fat
Vitamin D3 (2,000–5,000 IU) + MK-7 + CoQ10

Fat-soluble D3, K2 (MK-7), Omega-3 rTG, and CoQ10 Ubiquinol absorb 32%–50% better with dietary fat.

6:30 PM • Mid-Dinner GI Buffer
Metformin ER (500–1,000 mg)

Taking Extended-Release (ER) mid-dinner cuts GI nausea/diarrhea by >60%. Check Vitamin B12 + MMA yearly.

Atorvastatin (20 mg) or Rosuvastatin (10 mg)

Pairs cleanly with dinner alongside CoQ10 Ubiquinol (100–200 mg) to support muscle mitochondrial ATP.

9:30 PM • Bedtime 60m Pre-Sleep
Magnesium Bisglycinate (200–300 mg Elemental)

Safely separated 15 hours from morning Levothyroxine; glycine + Mg2+ support GABAergic deep sleep.

Verified 30-Day Generic Cash Price Check (Cost Plus & CMS NADAC Benchmark)

Never pay a $45–$68 retail pharmacy walk-in markup for pennies-per-pill generics:

Alphabetical Index • Letter "G"

Medications Starting With "G" (47)

Clear Filter × Page 1 of 2
Alpha-2-Delta Nerve Pain Modulator

Gabapentin (Neurontin / Gralise)

Brands: Neurontin • Gralise

Calms hyperexcitable dorsal horn calcium channels within 1–2 weeks to quiet sciatica, diabetic neuropathy, shingles pain, and RLS.

Price & Supply: $5.40 Generic Cash • $1.05 NADAC • RxCUI 25480
Charged Quaternary Ammonium Peripheral Eccrine M3 Muscarinic Blocker

Targets charged quaternary ammonium peripheral eccrine m3 muscarinic blocker pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $8.90 Generic Cash • $4.95 NADAC • RxCUI 4917
Decreased Central Nervous System Disorganized Electrical Activity

Gabapentin Enacarbil

Brands: Horizant

Targets decreased central nervous system disorganized electrical activity pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$501/mo NADAC • $453 Retail Avg
Gadolinium-based Contrast Agent

Gadobutrol

Brands: Gadavist • Pixxoscan

Targets gadolinium-based contrast agent pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$78.90/mo NADAC • $282 Retail Avg
Paramagnetic Contrast Agent

Gadodiamide

Brands: Omniscan

Targets paramagnetic contrast agent pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$59.10/mo NADAC • $216 Retail Avg
Gadolinium-based Contrast Agent

Gadoterate Meglumine

Brands: Dotarem • Clariscan

Targets gadolinium-based contrast agent pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$24.00/mo NADAC • $100 Retail Avg
Cholinesterase Inhibitor

Targets cholinesterase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $7.62 Generic Cash • $26.57 NADAC • RxCUI 860901
FDA Prescription Monograph

Targets fda prescription monograph pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$16.50/mo NADAC • $75 Retail Avg
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme

Galsulfase

Brands: Naglazyme

Targets hydrolytic lysosomal glycosaminoglycan-specific enzyme pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$37.50/mo NADAC • $145 Retail Avg • RxCUI 578037
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor

Ganciclovir

Brands: Zirgan

Targets cytomegalovirus nucleoside analog dna polymerase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$295/mo NADAC • $453 Retail Avg • RxCUI 388052
Gonadotropin Releasing Hormone Receptor Antagonist

Ganirelix Acetate

Brands: Fyremadel

Targets gonadotropin releasing hormone receptor antagonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $45.25 Generic Cash • $72.06 NADAC • RxCUI 855200
FDA Prescription Monograph

Garadacimab

Brands: Andembry

Targets fda prescription monograph pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$107/mo NADAC • $375 Retail Avg • RxCUI 2717175
Quinolone Antimicrobial

Gatifloxacin

Brands: Zymaxid

Targets quinolone antimicrobial pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $19.11 Generic Cash • $225.13 NADAC • RxCUI 992395
Central alpha-2 Adrenergic Agonist

Gaunfacine

Brands: Guanfacine

Targets central alpha-2 adrenergic agonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$4.20/mo NADAC • $36 Retail Avg
Kinase Inhibitor

Gedatolisib

Brands: Revtorpyk

Targets kinase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$72.90/mo NADAC • $262 Retail Avg
Kinase Inhibitor

Gefitinib

Brands: Iressa

Targets kinase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$104/mo NADAC • RxCUI 349472
Nucleoside Metabolic Inhibitor

Gemcitabine

Brands: Avgemsi

Targets nucleoside metabolic inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$560/mo NADAC • $453 Retail Avg • RxCUI 1720960
Peroxisome Proliferator Receptor alpha Agonist

Gemfibrozil

Brands: Lopid

Targets peroxisome proliferator receptor alpha agonist pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $7.26 Generic Cash • $3.02 NADAC • RxCUI 310459
CD33-directed Immunoconjugate

Gemtuzumab Ozogamicin

Brands: Mylotarg

Targets cd33-directed immunoconjugate pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$30.30/mo NADAC • $121 Retail Avg • RxCUI 1944701
Aminoglycoside Antibacterial

Gentamicin

Brands: Garamycin

Inhibits microbial cell-wall, ribosomal, or viral polymerase replication to clear targeted infections.

Price & Supply: $8.74 Generic Cash • $37.73 NADAC • RxCUI 1870676
FDA Prescription Monograph

Gepirone

Brands: Exxua

Targets fda prescription monograph pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$295/mo NADAC • $453 Retail Avg • RxCUI 2672372
Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor

Gepotidacin

Brands: Blujepa

Targets triazaacenaphthylene bacterial type ii topoisomerase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$295/mo NADAC • $453 Retail Avg • RxCUI 2709218
Histone Deacetylase Inhibitor

Givinostat

Brands: Duvyzat

Targets histone deacetylase inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$83.40/mo NADAC • $297 Retail Avg
Aminolevulinate Synthase 1-directed RNA Interaction

Givosiran Sodium

Brands: Givlaari

Targets aminolevulinate synthase 1-directed rna interaction pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$96.00/mo NADAC • $338 Retail Avg • RxCUI 2265716
Hedgehog Pathway Inhibitor

Glasdegib

Brands: Daurismo

Targets hedgehog pathway inhibitor pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$28.20/mo NADAC • $114 Retail Avg
FDA Prescription Monograph

Targets fda prescription monograph pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$295/mo NADAC • $453 Retail Avg • RxCUI 1111641
Sulfonylurea

Glimepiride

Brands: Amaryl

Targets sulfonylurea pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $5.34 Generic Cash • $0.89 NADAC • RxCUI 199246
Sulfonylurea

Glipizide

Brands: Glucotrol

Targets sulfonylurea pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $5.46 Generic Cash • $3.65 NADAC • RxCUI 310490
Corticosteroid

Targets corticosteroid pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$59.10/mo NADAC • $216 Retail Avg
Antihypoglycemic Agent

Glucagon

Brands: Baqsimi • Glucagon Emergency

Targets antihypoglycemic agent pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $94.41 Generic Cash • $150.34 NADAC • RxCUI 2180666
Carboxypeptidase

Glucarpidase

Brands: Voraxaze

Targets carboxypeptidase pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$58.80/mo NADAC • $215 Retail Avg
Sulfonylurea

Targets sulfonylurea pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: $5.74 Generic Cash • $4.82 NADAC • RxCUI 861748
Nitrogen Binding Agent

Targets nitrogen binding agent pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$33.00/mo NADAC • $130 Retail Avg • RxCUI 1368453
FDA Prescription Monograph

Targets fda prescription monograph pathways to control symptoms and support evidence-based outpatient management.

Price & Supply: ~$61.20/mo NADAC • $223 Retail Avg • RxCUI 310571
Connected Clinical Ecosystem • Conditions, Supplements & Specialists

Pair Your Prescription Guide With Diagnostic Cutoffs & Nutrient Depletion Rules

Medical Conditions (/conditions)

Diagnostic Lab Cutoffs & First-Line Protocols

See exact ACC/AHA blood pressure stages, ADA HbA1c thresholds, and step-up treatment ladders across 40 specialty hubs.

Dietary Supplements (/supplements)

Drug-Induced Nutrient Depletions & Label Math

Check when statins, Metformin, or PPIs deplete CoQ10, Vitamin B12, or Magnesium—and how to decode elemental supplement labels.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Find board-certified endocrinologists, cardiologists, and internists verified by CMS Medicare Part B volume and accepted insurance plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

How does dotMD.com verify FDA dosing and wholesale cash prices for Medications Starting With "G" (47)?

dotMD.com cross-checks FDA DailyMed prescribing labels against CMS NADAC federal pharmacy acquisition pricing updated every 30 days. Generic retail quotes regularly run 8x to 40x above wholesale ($0.45–$2.85 per 30 days), letting patients compare transparent cash pricing, ER vs. IR tolerability, and boxed warnings with 0% pharma sponsorship.

Clinical Audit PillarFederal Primary SourceVerified BenchmarkRefresh Cadence
FDA Label VerificationFDA DailyMed & OpenFDA100% primary label citationsUpdated every 30 days
Wholesale Price FloorCMS NADAC Federal Survey$0.45–$2.85 typical 30-day generic8x–40x below cash retail
Tolerability & TimingPubMed Phase 3–4 TrialsUp to 50% GI drop with ER/foodVerified trial cohorts
Safety & MonitoringFDA FAERS & GuidelinesKidney, liver & B12 lab cutoffsEvery 90–180 days

What safety and cost checks should patients review before filling Medications Starting With "G" (47)?

dotMD.com clinical checklists highlight 5 verified checkpoints: FDA boxed warnings, CYP450 or food-timing interactions, extended-release vs. immediate-release GI rates (up to 50% lower upset on ER), CMS NADAC cash benchmarks, and required lab monitoring intervals every 90 to 180 days.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee